T HE Rho family small GTPases play a fundamental
role in the regulation of cell shape and tissue morphogenesis in multicellular organisms. Activated, GTPbound Rho GTPases interact directly with a variety of effector proteins that mediate their cellular functions (Bishop and Hall 2000) . One such effector is protein kinase N (PKN), also known as protein kinase C-related kinase-1 (PRK1), which binds specifically to the activated Rho GTPase (Mukai 2003) . PKN contains a serine/ threonine kinase domain at its carboxyl terminus that is most closely related to the kinase domains of the protein kinase C (PKC) family kinases (Mukai and Ono 1994) . Its amino terminus contains three tandem motifs of $70 amino acids, each composed of a charged region followed by a leucine-zipper-like region. Structural analysis of the first repeat showed that it consists of two helices that form an anti-parallel coiled coil (ACC finger) (Maesaki et al. 1999) . Hence, these repeats are called the ACC domains. In the ''middle'' of PKN there is a region of unknown function with weak homology to the C2 domain of PKCs e and h (Mukai 2003) .
Two additional PKN isoforms have been identified in mammals: PKN-g/PRK 2 and PKN-b (Palmer et al. 1995; Quilliam et al. 1996; Vincent and Settleman 1997; Oishi et al. 1999) . These proteins share a similar domain structure to PKN but also have one or two proline-rich regions, respectively, between the C2-like domain and the kinase domain. PKN and PRK 2 are expressed ubiquitously, whereas expression of PKN-b mRNA has been detected only in a few cancer cell lines (Mukai and Ono 1994; Palmer et al. 1995; Quilliam et al. 1996; Oishi et al. 1999) . Closely related PKN orthologs have been identified in Drosophila, Xenopus, and starfish (Mukai et al. 1995; Ueno et al. 1997; Stapleton et al. 1998; Lu and Settleman 1999) .
PKN kinase activity is regulated in a variety of ways. Evidence indicates that the amino-terminal region of PKN serves to autoinhibit the activity of the kinase domain Kitagawa et al. 1996; Yoshinaga et al. 1999) . Consistent with a role for the amino-terminal half of PKN in regulating the kinase domain, active Rho was shown to bind to the ACC domains of PKN and stimulate its kinase activity, possibly by relieving autoinhibition (Amano et al. 1996; Watanabe et al. 1996) . Activated Rho as well as Rac can also bind and activate the PKN-related PRK2 protein (Quilliam et al. 1996; Vincent and Settleman 1997) . PKN is also activated by unsaturated fatty acids such as arachadonic acid and by autophosphorylation Peng et al. 1996) . Phosphorylation on amino acid S377 is required for PKN localization to the plasma membrane and is essential for PKN to function as a Rho effector in mammalian cells (Zhu et al. 2004) . Activation loop phosphorylation of PKN and PRK2 by PDK1 is important for their activation in vitro and in vivo and is required for PKN to transduce signals from the insulin receptor to the actin cytoskeleton (Dong et al. 2000; Flynn et al. 2000) . 1 In addition to the Rho GTPases, several proteins have been identified that interact with PKN family members. These include signaling proteins such as p38 MAP kinases, MKK3, MKK6, MLTKa, PDK1, MEKK2, Akt, phospholipase D, NCK, Graf/Graf2, and cyclin T2a (Quilliam et al. 1996; Flynn et al. 2000; Koh et al. 2000; Sun et al. 2000; Oishi et al. 2001; Shibata et al. 2001; Takahashi et al. 2003 Cottone et al. 2006 ; transcription factors such as the androgen receptor, NRDF/ NeuroD2, and PCD17 (Takanaga et al. 1998; Shibata et al. 1999; Metzger et al. 2003) ; and cytoskeletal proteins such as neurofilament protein, vimentin, and a-actinin (Mukai et al. 1996b Matsuzawa et al., 1997) . However, in most cases, the physiological significance of these interactions has not been determined. In addition, several potential substrates for the kinase activity of PKN or PRK2 have been reported. These include phospholipase D, Graf/Graf2, neurofilaments, vimentin, tau, glial fibrillary acidic protein, and MLTKa (Mukai et al. 1996b; Matsuzawa et al. 1997; Oishi et al. 2001; Shibata et al. 2001; ; Taniguchi et al. 2001; Takahashi et al. 2003) . But again, the in vivo relevance of these phosphorylations is not clear.
Various cellular functions have been attributed to PKN family members, including potential roles in cell cycle regulation and apoptosis (Cryns et al. 1997; Stapleton et al. 1998; Takahashi et al. 1998; Koh et al. 2000; Misaki et al. 2001; Isagawa et al. 2005; Schmidt et al. 2007; Su et al. 2007) . Consistent with their putative role as Rho effectors, PKN and PRK2 have also been implicated in regulation of the actin cytoskeleton (Vincent and Settleman 1997; Dong et al. 2000; Bourguignon et al. 2004; Lim et al. 2004; Darenfed et al. 2007) . Several studies have also suggested a role for PKN proteins in transcriptional regulation. For example, PKN can regulate SRF-dependent transcription and has been implicated in regulating gene expression via the p38 MAP kinase pathway (Marinissen et al. 2001; Gudi et al. 2002; Deaton et al. 2005) . In addition, PKN has also been shown to bind to the androgen receptor and stimulate its transcriptional activity (Metzger et al. 2003) .
At the organismal level, the functions of PKN proteins are poorly understood. There is a single PKN ortholog, Pkn, encoded by the Drosophila genome (Ueno et al. 1997; Lu and Settleman 1999) . Pkn binds specifically to the activated forms of Rho and Rac GTPases in vitro (Lu and Settleman 1999) . We determined previously that homozygous mutants in the Pkn gene are lethal and exhibit specific defects in dorsal closure, a developmental process in which Rho and Rac GTPases have been directly implicated (Lu and Settleman 1999) . The Pkn gene product appears to be required for the changes in epidermal cell shape that take place during this morphogenetic process (Lu and Settleman 1999) . Here, we report studies in which we have used Drosophila as a model system to perform a structure-function analysis of Pkn in vivo. We specifically set out to determine whether Rho and/or Rac binding is required for Pkn function in vivo and to establish the functional relationship between Pkn and the other closely related kinases of the PKC family.
MATERIALS AND METHODS

Molecular biology:
The Pkn G58A and Pkn KD mutants have been described previously (Lu and Settleman 1999) . These cDNAs were amplified by PCR using Pfu turbo (Stratagene, La Jolla, CA) and subcloned into the pCMV5-flag vector for transient expression in mammalian cells and into pCaSpeR-hs for generation of transgenic flies. Chimeras and deletions of Pkn and PKC53E were generated by PCR using overlapping primers. The cDNA templates used are as follows: Pkn (Lu and Settleman 1999) , DPak (DGRC, Indiana), PKC53E-B (Drosophila Gene Collection at BDGP), Drok (Verdier et al. 2006) , and the mouse Rhotekin Rho-binding domain (Ren and Schwartz 2000) . The PCR products were subcloned into the pCMV5-flag vector and into pCaSpeR-hs. In addition, the kinase domains of Pkn and PKC53E were amplified by PCR and subcloned into the pUAS-T vector. All constructs were sequenced before use.
GTPase binding assays: 293-T cells were transfected with Pkn and Pkn mutants or PKC53E and PKC53E chimeras that had been subcloned into the CMV5-flag vector. Cell extracts were prepared 48 hr after transfection in lysis buffer ½50 mm HEPES (pH 7.4), 150 mm NaCl, 1.5 mm MgCl 2 , 5 mm EGTA, 10% glycerol, 1% Triton X-100. Lysates were precleared twice for 30 min at 4°with protein A-Sepharose beads before use in binding assays. Drosophila Rho1 and Rac1 GST fusion proteins were expressed in Escherichia coli bacteria and purified according to standard methods. Equal amounts of GST fusion proteins and GST ($10 mg/assay) were incubated at 30°for 30 min in 50 ml of nucleotide exchange buffer ½50 mm HEPES (pH 7.08), 5 mm EDTA, 0.1 mm EGTA, 50 mm NaCl, 0.1 mm DTT, 0.5 mm GTPgS to load the proteins with GTPgS. The reaction was terminated by addition of MgCl 2 to a final concentration of 20 mm. Precleared lysates were incubated with the GST-GTPases and glutathione agarose beads at 4°for 1 hr. The beads were then washed four times in wash buffer ½20 mm HEPES (pH 7.5), 150 mm NaCl, 10% glycerol, 0.1% Triton X-100 and analyzed by SDS-PAGE, followed by immunoblotting with anti-Flag M2 monoclonal antibody (Sigma, St. Louis). One-percent samples of the lysates (1% of the input) were also resolved by SDS-PAGE and immunoblotted with the M2 antibody.
Germline transformation and heat-shock rescue: All Drosophila stocks were maintained at 25°. Transgenic flies were generated by co-injection of the transgene with the D2-3 transposase into w 1118 embryos prior to cellularization. At least four transgenic lines for each pCaSpeR-hs construct were introduced into the Pkn P mutant background (Lu and Settleman 1999) . To test the ability of the transgenes to rescue the lethality associated with the P-element insertion in the Pkn gene, $40 Pkn P /CyO virgins were crossed to 15-20 males of each transgenic line in the Pkn P mutant background. The F 1 progeny growing at 25°were subjected to 30-min heat shock at 37°once a day beginning 48 hr after egg laying until eclosion. For the Pkn-PKC53E transgene, 15-min heat shocks were performed, since longer heat shocks caused lethality. For each cross, the number of Cyo-balanced and nonbalanced flies was determined. On the basis of expected Mendelian ratios, the percentage of flies that could be rescued to adulthood was calculated for each line.
RT-PCR:
To test expression of the transgenes induced by heat shock, RT-PCR was performed on RNA extracted from heat-shocked larvae. Wandering third instar larvae were heatshocked at 37°and incubated at 25°for 30-40 min to recover. Fifteen heat-shocked and 15 non-heat-shocked larvae were picked from each cross and lysed in 1 ml Trizol (Invitrogen, Carlsbad, CA). After centrifugation to remove the larval cuticles, chloroform was added to extract the RNA. The RNA was precipitated using isopropanol. RNA was then treated with DNAse using the DNA-free kit (Ambion, Austin, TX) according to the manufacturer's instructions. First-strand cDNA synthesis was performed with 1 mg RNA using random primers and the First-Strand DNA synthesis kit (Amersham/GE Healthcare, Piscataway, NJ) or the Protoscript II RT-PCR kit (New England Biolabs, Beverly, MA) according to the manufacturer's instructions. PCR was then performed using primers specific to the transgene. PCR products were resolved on an ethidium bromide-agarose gel.
Wing morphology: Virgin females carrying the UAS-Pkn and UAS-PKC53E transgenes were crossed to w 1118 males or to the following GAL4 driver lines: Act88f-GAL4, engrailed-GAL4 (en-GAL4), patched-GAL4 (ptc-GAL4), and Cy6-GAL4. The progeny were allowed to develop to adulthood. Wings were examined for changes in morphology, veination pattern, and wing hairs. For documentation, wings were removed and mounted on slides in Gary's Magic mounting medium.
COS cell transfection and immunofluoresence: COS cells were seeded onto glass coverslips in six-well plates at 1-2 3 10 5 cells per well. When cells reached 50% confluence, they were transfected with Pkn, Pkn mutants, PKC53E, or PKC53E chimeras in the CMV5-flag vector using Lipofectamine 2000 (Invitrogen). At 24 hr post-transfection, cells were fixed in 3% paraformaldehyde. Cells were then permeabilized with 0.1% Triton and stained with the M2 mouse anti-flag monoclonal (Sigma), followed by Cy2-conjugated goat anti-mouse IgG ( Jackson, West Grove, PA) and finally with DAPI. Coverslips were mounted onto glass slides using ProLong Gold anti-fade reagent (Invitrogen).
RESULTS
Rho GTPase binding is required for efficient Pkn function during Drosophila development:
In previous studies, we have generated a null mutation of Pkn that exhibits a lethal phenotype. This lethality is associated with defective dorsal closure (Lu and Settleman 1999) but Pkn mutants that were able to progress through embryogenesis die at larval or pupal stages, suggesting additional roles for Pkn later in development (data not shown). We were able to rescue the lethality of the Pkn mutant by expressing a full-length Pkn cDNA in transgenic flies under the control of a heat-shock promoter (Lu and Settleman 1999) . We also determined that the rescued flies (males and females) do not exhibit any detectable defects in fertility (data not shown). To determine which of the various domains of the Pkn protein are important for its developmental function in vivo we made use of this system in structure-function studies.
We first examined the requirement for Rho and Rac binding for Pkn function. Studies in mammalian cells have mapped the Rho-and Rac-binding region of Pkn to three tandem leucine-zipper repeats situated near the amino terminus of the protein (the ACC domains) Maesaki et al. 1999) . We previously identified a missense mutation (G58A) in the first leucine-zipper repeat of Pkn (ACC1) that substantially reduces binding to Rac but not to Rho in in vitro protein interaction studies (Lu and Settleman 1999) , suggesting that this domain is critical for Rac binding. In an effort to map more precisely the binding sites for Rho and Rac on Pkn, we generated specific deletions of the ACC1 domain (DACC1), the ACC2 domain (DACC2), and both domains together (DACC12; see Figure 1A ). These various deletion constructs were expressed in transfected cells and binding to Drosophila Rho and Rac1 was assayed by ''pull-down'' using GST-tagged recombinant Rho and Rac GTPases. As shown in Figure  1B , deletion of ACC1 reduces Rho binding and practically abolishes Rac binding. Deletion of the ACC2 domain does not affect Rho and Rac binding. Upon deletion of both domains a residual amount of Rho binding remains, but no Rac binding can be observed. This suggests that Rac1 binds to the ACC1 domain, whereas Rho binds to both the ACC1 and ACC2 domains. In addition, a construct that lacks the amino terminus of the protein, as well as all three AC domains (DACC123), exhibits no detectable binding to Rho1 and Rac1 ( Figure 1C ), suggesting that Rho may also interact with the ACC3 domain.
The G58A mutant and the ACC1, ACC2, ACC12, and ACC123 deletions were subcloned into the pCaSpeR-hs (heat-shock) vector and injected into Drosophila embryos to generate transgenic animals. Four independent lines for each transgene were introduced into the Pkn P mutant background. The flies thus generated were crossed to Pkn P mutant flies. The F 1 progeny of the cross were heat-shocked for 30 min every day from 48 hr after egg laying to eclosion to induce expression of the transgene. This heat-shock regimen was chosen because it produces the greatest rescue of the lethality of the Pkn P mutant when the full-length, wild-type Pkn transgene is used (data not shown). The adults were examined to determine whether expression of the transgenes could rescue lethality of the Pkn mutant flies. The percentage of rescue was determined for each line and compared to that observed upon expression of full-length, wild-type Pkn (Table 1) . We found that expression of the G58A mutant was able to rescue the Pkn loss-of-function phenotype to a similar degree as wild-type Pkn, indicating that Rac binding is not required for Pkn function in vivo, at least in terms of maintaining viability. This is supported by the fact that the DACC1 mutant was also able to rescue lethality of Pkn mutant flies (Table 1 ). The ability of the various independently generated DACC1 mutant lines to rescue the Pkn phenotype appears to be correlated with the level of expression of the transgene, as shown by RT-PCR (supplemental Figure 1 at http:// www.genetics.org/supplemental/).
The DACC2 deletion construct rescued the Pkn P lethality with an efficiency similar to that of wild-type Pkn (Table 1) . In contrast, the DACC12 transgene carrying a deletion of both the ACC1 and the ACC2 domains was able to rescue lethality only with low efficiency (Table 1) . These findings suggest that Rho1 binding is required for full Pkn function, but that residual in vivo function is preserved with little Rho1 binding. The DACC123 construct, in contrast, exhibited virtually no ability to rescue the lethality of the Pkn P mutant (Table 1) . Attempts to generate an antibody that specifically recognizes Pkn in Drosophila have so far been unsuccessful. Thus, it was not possible to determine whether the transgenes were expressed at the protein level. However, the fact that expression of all transgenes at the RNA level was confirmed by RT-PCR (supplemental Figure 1 at http:/ / www.genetics.org/supplemental/), together with the observed efficient expression of these mutant proteins in transfected cells and their ability to bind activated Rho1 and Rac1 in vitro, suggests that the observed phenotypes do not reflect defects in transgene expression.
To further explore the role of Rho and Rac binding in the function of Pkn in vivo, chimeric constructs were generated in which the ACC domain of Pkn was replaced with the Rho-binding domains of Drosophila Rho-kinase (Rok) or mouse Rhotekin, or the Racbinding domain of DPak (see Figure 1A ). These mutant proteins exhibited the expected Rho/Rac-binding properties when examined in pull-down experiments. Thus, the Rok-Pkn and Rhotekin-Pkn chimeric proteins bind efficiently to Rho1, but not to Rac1, whereas Pak-Pkn binds only to Rac1 ( Figure 1C ). Transgenic flies were generated that expressed the Pak-Pkn, Rok-Pkn, and Rhotekin-Pkn chimeras under control of the heat-shock promoter. The transgenes were introduced into the Pkn P mutant background and tested for their ability to rescue the lethality of this mutant. Four lines were tested for each transgene and the expression of the transgenes upon heat shock was confirmed by RT-PCR (supplemental Figure 1 at http:/ /www.genetics.org/supplemental/). Interestingly, none of the lines was able to rescue the Pkn P mutant (supplemental Table 1 ), suggesting that another function of the amino-terminal region of Pkn, in addition to Rho/Rac GTPase binding, is required for its role in development.
One potential explanation for the inability of the DACC123 deletion and the Pak-Pkn, Rok-Pkn, and Rhotekin-Pkn chimeras to rescue lethality in the Pkn mutant background is that they may exhibit aberrant G58A mutation, and DACC deletions to Rho1 and Rac1. Flag-tagged Pkn and the various deletions were transfected into 293-T cells. Pulldown assays were performed using GTPgS-loaded recombinant GST-Rho1, GST-Rac1, or GST. Pull downs (left) and samples of the lysates (right) were resolved on SDS-PAGE gels, blotted to PVDF, and probed with an anti-flag antibody. (C) Binding of Pkn, the DACC123 deletion, and the Pak-Pkn, Rok-Pkn, and Rhotekin-Pkn chimeras to Rho1 and Rac1. Pull-down binding assays were performed as described in B. The pull downs are shown on the left and samples of the lysates are shown on the right. subcellular localization. We determined that flag-tagged versions of Pkn, Pkn G58A , DACC1, DACC2, and DACC12 show a diffuse localization throughout the cytoplasm and are excluded from the nucleus when expressed in mammalian COS cells (supplemental Figure 2 , A, B, and J, at http://www.genetics.org/supplemental/). In contrast, in 17-32% of cells expressing DACC123, PakPkn, Rok-Pkn, or Rhotekin-Pkn, the tagged proteins localize to vesicular structures that are either distributed throughout the cell or clustered around the nucleus (supplemental Figure 2, C, D, and J) .
The C2-like domain is dispensable for Pkn function during development: In the central region of Pkn, there is a domain of unknown function that exhibits homology to the C2 domains of PKC e and h, two novel PKCs (Mukai 2003) . To determine whether this domain is important for Pkn function in vivo, a construct was generated in which this domain is deleted (DC2). This was cloned into the pCaSpeR-hs vector, transgenic flies were generated, and the ability of the DC2 transgene to rescue the lethality of the Pkn mutant was determined.
Each of the four lines tested rescued the Pkn mutant lethality (Table 2) . One line exhibited substantial rescue (39%), though less than that seen with wild-type Pkn. The other lines rescued to a lesser extent (Table 2) . These results suggest that the C2 domain is not absolutely required for Pkn function during development. In 18% of COS cells expressing the transfected DC2 mutant, the protein localizes to vesicular structures (supplemental Figure 2I at http://www.genetics.org/ supplemental/), which may explain the reduced ability to rescue the lethality of the Pkn P mutant in comparison to wild-type Pkn.
Distinct properties of the closely related kinase domains of Pkn and PKC53E: The kinase domain of Pkn most closely resembles the kinase domain of the PKC family kinases. In fact, evolutionary studies indicate that Pkns and PKCs have a common evolutionary ancestor (Herold et al. 2002) . In yeast, a single PKN/PKClike molecule exists that has domains similar to the ACC domains of Pkn and to the C1 and C2 domains of PKCs. In Drosophila, there are five PKCs: PKC53E, PKC98E, aPKC, PKCd, and inaC (Shieh et al. 2002) . Of these, the kinase domains of PKC53E and PKC98E, two PKCs of unknown function, show the highest similarity to the kinase domain of Pkn (65 and 69% similarity, respectively). Therefore, we chose these two PKC kinases for further study. To begin to address the role of the PKN kinase domain in vivo, we first compared the activity of the kinase domains of Pkn and PKC53E. The isolated kinase domains of Pkn and PKC53E were cloned into the pUAS-T vector to allow expression under control of the UAS promoter. Transgenic flies were generated carrying each UAS-kinase domain and these flies were crossed to a variety of GAL4 driver lines to drive transgene expression in the wing. Distinct phenotypes were observed for each kinase domain. The Act88f driver Percentage of rescue was determined by counting the number of CyO-balanced and nonbalanced flies and calculating the percentage of flies that could be rescued to adulthood on the basis of expected Mendelian ratios. The total number (n) of flies counted is shown in parentheses. Relative mRNA expression of the transgenes was estimated from ethidium bromide-agarose gels of RT-PCR products. For each transgene: 111, the line that gave the strongest PCR band; 11, the line with the second strongest bands; 1, the weakest; À, no expression. Percentage of rescue was determined by counting the number of CyO-balanced and nonbalanced flies and calculating the percentage of flies that could be rescued to adulthood on the basis of expected Mendelian ratios. The total number (n) of flies counted is shown in parentheses. Relative mRNA expression of the transgenes was estimated from ethidium bromideagarose gels of RT-PCR products. For each transgene: 111, the line that gave the strongest PCR band; 11, the line with the second stongest bands; 1, the weakest; À, no expression.
caused subtle ectopic wing veination from the posterior cross vein (pcv) in a subset of wings expressing the Pkn kinase domain but much more substantial ectopic veination from the pcv and L2 vein in wings expressing the PKC53E kinase domain (Figure 2C and D) . Overexpression of the Pkn kinase domain using the en and ptc drivers produced an alteration in wing hair polarity and a multiple wing hair phenotype, as well as a reduction in wing material in the expression domains (Figure 2 , E and G). Interestingly, Rho1 has been implicated in regulation of wing hair polarity (Strutt et al. 1997) . In contrast, overexpression of the PKC53E kinase domain using the same drivers produced no obvious phenotype (Figure 2, F and H) . Expression of the Pkn kinase domain in the wing margin using the Cy6 driver led to missing bristles at the anterior wing margin and missing hairs at the posterior wing margin, as well as longer posterior margin hairs ( Figure 2I ), whereas expression of PKC53E with this driver produced an occasional loss of material at the wing margin but no other defects ( Figure 2J ). Overall, we observed considerable differences in the phenotypes caused by overexpression of the Pkn kinase domain vs. the PKC53E kinase domain. This suggests that there are intrinsic differences in the signaling capacity of Pkn and PKC kinase domains in vivo.
The kinase domain of PKC53E can functionally substitute for the kinase domain of Pkn: To confirm that the kinase domain of Pkn is indeed required for Pkn function in vivo, the ability of a kinase-defective mutant of Pkn to rescue the lethality of the Pkn mutant was tested. The kinase-defective Pkn mutant contains a lysine-to-methionine substitution at amino acid 892 ( Figure 1A ). Four independent transgenic lines were tested and none of them was able to rescue, despite induction of transgene expression upon heat shock, as demonstrated by RT-PCR (supplemental Figure 1 at http://www.genetics.org/supplemental/). This strongly suggests that the kinase activity of Pkn is absolutely required for its in vivo function. Interestingly, Pkn KD exhibits some nuclear localization when expressed in transfected COS cells, which suggests that kinase activity may be important for correct compartmentalization of Pkn (supplemental Figure 2J) .
As described above, the kinase domain of Pkn is highly related to that of PKCs. To determine whether the kinase domain of Pkn could be functionally substituted by that of a PKC, chimeras were constructed in which the kinase domain of Pkn was replaced with that of PKC98E or PKC53E ( Figure 3A) . Transgenic lines were generated with these constructs under control of the heat-shock promoter and the ability of these chimeras to rescue the lethality of the Pkn mutant was tested. Using the standard heat-shock regimen (30 min heat shock once a day), these chimeras caused substantial lethality. If the length of heat shock was reduced to 15 min per day, the ability of the Pkn-PKC53E chimera to cause lethality was greatly reduced, and in fact, the Pkn-PKC53E chimera was able to rescue the lethality of the Pkn mutant (Table 3 ). In contrast, the Pkn-PKC98E chimera still caused substantial lethality with a 15-min heat shock. If the length of heat shock was reduced to 5 min, the Pkn-PKC98E transgene caused less lethality, but was unable to rescue to the Pkn mutant. However, since the ability of wild-type Pkn to rescue was substantially reduced under these heat-shock conditions, the Pkn-PKC98E chimera may not have been expressed at sufficient levels using 5-min heat shocks to rescue the lethality of the Pkn mutant. Both chimeras induce dramatic changes in cell shape when expressed in transfected COS cells (supplemental Figure 2 , G and H, at http://www.genetics.org/supplemental/). The cells exhibit long protrusions and often become thin and spindly. The shape changes are more extreme with the Pkn-PKC98E chimera than with the Pkn-PKC53E chimera. This phenotypic effect of overexpression may contribute to the lethality associated with these chimeras when expressed in flies.
In contrast to the rescue observed with the Pkn-PKC53E chimera, full-length, wild-type PKC53E was unable to rescue the Pkn mutant phenotype, suggesting that domains other than the kinase domain are important for Pkn function (data not shown). Therefore, we generated and tested additional chimeras in which the Rho-binding domains of DRok or mouse Rhotekin or the Rac-binding domain of DPak were fused to the amino terminus of PKC53E ( Figure 3A ). Binding to Rho and Rac1 was determined by GST pull-down assay. The Pak-53E chimera bound strongly to Rac1 and very weakly to Rho1. The Rok-53E chimera bound strongly to Rho1 and weakly to Rac1. In contrast, the Rhot-53E chimera bound only to Rho1 ( Figure 3B ). These chimeras were introduced into flies and four independent transgenic lines of each were tested for the ability to rescue the Pkn For the Pkn-PKC53E chimera, the kinase domain of Pkn was replaced with that of PKC53E. (B) Binding of Pkn, PKC53E, and the Pak-53E, Rok-53E, and Rhot-53E chimeras to Rho1 and Rac1. Pull-down binding assays were performed as described in Figure 1B . The pull downs are shown on the left and samples of the lysates are shown on the right.
TABLE 3
The kinase domain of PKC53E can functionally substitute for that of Pkn Percentage of rescue was determined by counting the number of CyO-balanced and nonbalanced flies and calculating the percentage of flies that could be rescued to adulthood on the basis of expected Mendelian ratios. The total number (n) of flies counted is shown in parentheses. Relative mRNA expression of the transgenes was estimated from ethidium bromide-agarose gels of RT-PCR products. For each transgene: 111, the line that gave the strongest PCR band; 11, the line with the second stongest bands; 1, the weakest; À, no expression. ND, not determined. mutant. However, none of these chimeras was able to rescue the lethality associated with Pkn disruption. The expression of the transgenes in each line was confirmed by RT-PCR (supplemental Figure 1 at http:/ /www.genetics. org/supplemental/). These data indicate that the Pkn amino-terminal half provides a function in addition to GTPase binding that is important during Drosophila development. Taken together, these findings also suggest that the closely related PKC53E catalytic domain can be imparted with context-dependent biological function via regulatory elements in the nonkinase domains of Pkn.
A defect in wing morphogenesis cannot be rescued with transgenic Pkn: During the course of conducting the structure-function rescue experiments, we observed that a substantial proportion of the rescued adult flies exhibited abnormalities associated with wing vein formation-either extra or missing wing vein material, particularly at L2 and the pcv (Figure 4 , A-C). In addition, some flies exhibited substantially smaller wings in comparison to those of wild-type flies (see Figure 4D ). This was seen for each of the transgenes that was capable of rescuing the lethality of the Pkn mutant. When the percentage of flies with wing vein alterations or reduced wing size was determined for each line that rescued, it was observed that there was a significant variation among transgenic lines with respect to the percentage of flies that exhibit these wing phenotypes. Similar proportions of flies rescued with the G58A mutant and the DACC1 transgenes exhibited vein defects in comparison to flies rescued with the wild-type Pkn transgene (Table 4) . However, a larger proportion of flies rescued with the DACC2 and DACC12 constructs displayed vein phenotypes. This was even more marked for flies rescued with the DC2 construct where virtually all the flies exhibited wing vein alterations (Table 4) .
There are three possible explanations for these wing phenotypes. First, they could result from overexpression of the Pkn transgenes upon heat shock. To determine whether this was the case, the two independent lines carrying the wild-type Pkn transgene under control of the heat-shock promoter were crossed to w 1118 flies. The progeny were heat-shocked from 48 hr after egg laying until eclosion and adults were examined for wing phenotypes. At least 200 adults were scored for each transgene and none of them exhibited any wing defects. This suggests that the observed wing phenotypes are not a consequence of transgene overexpression. A second possible explanation is that the wing phenotype is a dominant phenotype caused by the Pkn mutation or a mutation in another gene carried on the same chromosome, which may go undetected in most crosses because the chromosomes were balanced over a CyO balancer. To test this possibility, Pkn P /CyO flies were crossed to w 1118 flies and the wings of Pkn P /1 progeny were examined. None of the 200 flies scored showed any wing phenotypes, suggesting that the wing phenotypes observed in the rescued flies are not the result of a dominant mutation on the Pkn P chromosome (Figure 4 ). This is consistent with the fact that the penetrance of the phenotypes varies from one transgenic line to another. Thus, the most likely explanation for the observed wing phenotypes is that Pkn plays a role in normal wing morphogenesis and vein development and that this function for Pkn cannot be fully rescued in the Pkn mutant background by heat-shock-induced expression of a Pkn transgene. The observed wing phenotypes reveal the only specific developmental requirement, other than dorsal closure, that we have been able to identify for Pkn thus far.
DISCUSSION
The PKN family kinases are established biochemical effectors of Rho/Rac GTPase signaling; however, their functional role in the context of cellular and developmental biology is poorly understood. To begin to model the biological function of PKN in vivo, we had previously cloned the single PKN ortholog in Drosophila, Pkn, and generated a loss-of-function mutant (Lu and Settleman 1999) . The Pkn gene is essential for normal development, and homozygous mutant animals exhibit specific defects in dorsal closure, reflecting an apparent requirement for Pkn in tissue morphogenesis during gastrulation.
In the studies described here, we have utilized this experimental system to begin to elucidate the structurefunction relationship of Pkn in the context of Drosophila larval and pupal development. Our observations lead to the following conclusions: (1) Rac GTPase binding is completely dispensable for the developmental function of Pkn; (2) Rho GTPase binding to Pkn appears to be important for the developmental function of Pkn; (3) the kinase function of Pkn is essential for its role in development; (4) the C2-like domain of Pkn is not absolutely required for its role in development; (5) the PKC53E catalytic kinase domain can functionally substitute for the Pkn kinase domain during development; and (6) Pkn is required for normal wing morphogenesis.
The structural organization of domains within the PKN proteins suggests that these proteins might simply function as Rho/Rac-binding PKC-like kinases. In such a scenario, the interaction of PKNs with activated Rho and Rac GTPases might serve to localize their PKC-like kinase activity to a particular membrane region. This would be analogous to the documented roles of other small GTPases with their kinase effectors. For example, the activated Ras GTPase recruits the Raf kinase to the plasma membrane, and the oncogenic function of Raf can be realized by adding the C-terminal ''CAAX'' domain from Ras to the Raf protein (Leevers et al. 1994) . However, our findings suggest a more complex picture for the regulation of PKN activity in vivo. For example, the Rok-Pkn or Rhot-Pkn chimeras, which can efficiently bind the activated Rho GTPase, are unable to rescue the lethality associated with disruption of Pkn, suggesting that the Pkn amino terminus and ACC domains provide an essential function beyond Rho binding, although it is also possible that these chimeras were not correctly folded or properly localized in the cell. Notably, the fact that Rac binding is dispensable for Pkn's developmental function does not necessarily rule out the possibility that this interaction is required for a very subtle aspect of development that was not detected or for a physiological role of Rac-Pkn binding in the adult fly.
The cellular functions of PKN proteins may be controlled, in part, through regulation of their subcellular localization. Endogenous mammalian PKN has been detected in the cytoplasm and is associated with membranes, but in response to stresses such as heat shock, PKN translocates to the nucleus (Mukai et al. 1996a) . In contrast, in response to hyperosmotic stress, PKN translocates to a vesicular compartment (Torbett et al. 2003) . Similarly, overexpressed PKN has also been detected in endosomes . In keratinocytes that lack cell-cell adhesions, the PKN-related PRK2 kinase is diffusely distributed in the cytoplasm and membrane; however, when cell-cell adhesion is stimulated, PRK2 is recruited to the plasma membrane (Bourguignon et al. 2004) . Thus, the regulation of PKN subcellular localization may be critical for its biological activity, and this appears to be determined by more than simply the ability to bind activated Rho GTPases. Consistent with this, our analysis of the subcellular localization of the various constructs used for rescue in COS cells suggests that there is some correlation between localization and ability to rescue. For example, DACC123, DC2, and the Pak-, Rok-, and Rhotekin-Pkn chimeras all localize to vesicles in a subset of expressing cells (supplemental Figure 2 at http:// www.genetics.org/supplemental/). Some other mutants exhibit a partial nuclear localization, which is not observed with full-length, wild-type Pkn.
The Drosophila Pkn kinase domain is most closely related to that of the PKC family kinases, PKC53E and PKC98E, whose function in Drosophila has yet to be reported. Our observation that the PKC53E kinase domain can functionally substitute for that of Pkn during development suggests that these two kinases largely overlap in their spectrum of potential phosphorylation substrates in vivo. Interestingly, however, our finding that expressing the isolated catalytic domains of each of these kinases leads to a very distinct set of phenotypes in the developing wing, suggests that additional regulatory domains of these proteins play an important role in establishing the functional context of their activities.
This also highlights how the evolutionary ''strategy'' of combining functional domains can produce functionally distinct proteins that would otherwise appear to be highly related on the basis of shared motifs. We note that the observed differences between PKC53E and Pkn do not appear to reflect differences in their expression levels since multiple different transgenic lines of each, with varying levels of expression, were associated with distinct phenotypes.
With regard to the Pkn-PKC53 chimera that we generated, it is possible that the Pkn amino terminus localizes the PKC53E kinase domain to a particular subcellular region where a subset of biologically relevant ''PKC substrates'' resides. Thus, these results may reflect ''compartmentalized signaling,'' a theme that is emerging within the signal transduction literature (Mor and Philips 2006) . Notably, another closely related PKC-like kinase, PKC98E, is unable to rescue Pkn-associated developmental defects, when expressed as a chimera with the amino terminus of Pkn. This might reflect a small but important difference in the substrate specificity of the various PKC-like kinases. Similarly, the diminished efficiency with which the Pkn-PKC53E chimera rescues Pkn-associated lethality (relative to wild-type Pkn) could also reflect a suboptimal interaction between a critical Pkn phosphorylation substrate and the PKC53E kinase domain. However, it is also possible that such chimeras are not optimally folded and consequently exhibit reduced biological activity.
The wing defects observed in a large fraction of the rescued Pkn mutant flies indicate an essential role for Pkn in wing morphogenesis. This is the first specific role identified for Pkn in postembryonic fly development and is consistent with several reports indicating a requirement for Rho GTPase signaling in several aspects of wing morphogenesis (Bayer et al. 2003; Chen et al. 2005; Denholm et al. 2005) . Notably, several additional Rho pathway effectors have been implicated in wing morphogenesis, including Rho-kinase, lim-kinase, and diaphanous (Winter et al. 2001; Chen et al. 2004; Verdier et al. 2006) . The fact that a heat-shock protocol for expressing transgenic Pkn in these studies fails to rescue this particular developmental phenotype might reflect a requirement for especially high levels of expression in a subset of developing wing cells. A substantial proportion of flies rescued with the ACC2 and ACC12 domain-deleted transgenes exhibited vein alterations, suggesting the ACC2 domain, which is entirely dispensable for development, may play a specific role in wing morphogenesis and that Rho binding may be important for this process. In contrast, rescue with the constructs that show perturbed Rac binding (the G58A mutant and DACC1 deletion) did not produce enhanced wing vein phenotypes in comparison to rescue with wild-type Pkn, suggesting that Rac binding is not involved in wing morphogenesis. Most strikingly, the vast majority of flies rescued with the C2 domain-deleted Pkn mutant exhibited vein defects. This was true for four independently generated transgenic lines and suggests that this domain, which does not appear to be absolutely required for Drosophila development, may provide a critical regulatory component for Pkn function during wing morphogenesis.
In summary, we have used a transgene-rescue strategy to begin to dissect the functional domains of the multidomain Rho effector kinase, Pkn, in the context of its biological role in development. These studies have revealed several new aspects of Pkn regulation and function that could potentially be extended to the mammalian PKNs, which share a closely related arrangement of structural domains. They also exemplify the evolutionary strategy of combining functional domains to produce proteins with distinct biological activities.
